Charles Schwab Investment Management Inc Pulmonx Corp Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Pulmonx Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 320,946 shares of LUNG stock, worth $847,297. This represents 0.0% of its overall portfolio holdings.
Number of Shares
320,946
Previous 315,532
1.72%
Holding current value
$847,297
Previous $2.14 Million
0.79%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding LUNG
# of Institutions
127Shares Held
32.5MCall Options Held
2.6KPut Options Held
216K-
Primecap Management CO Pasadena, CA5.41MShares$14.3 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.49MShares$9.22 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$7.04 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$6.03 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.89MShares$4.99 Million0.32% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $98.4M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...